ABSTRACT
A selective and sensitive high performance liquid chromatography-electrospray ionization mass spectrometry method has been developed for the determination of tolterodine tartrate in human plasma. Tolterodine tartrate was extracted from plasma with n-hexane: isopropanol (95:5, v/v). The organic layer was evaporated and the residue was redissolved in mobile phase comprised of acetonitrile–water (10mM CH3COONH4, pH 3.0) = 55:45 (v/v). An aliquot of 10 µl was chromatographically analyzed on a prepacked ZORBAX XDB-ODS C18 column (2.1mm×30mm, 3.5 micron) particles by means of selected-ion monitoring (SIM) mode mass spectrometry. Standard curves were linear (r = 0.998) over the concentration range of 0.05–30.0 ng/ml and had good accuracy and precision. The limit of detection (LOD) was 0.02 ng/ml. The validated LC–ESI–MS method has been used successfully to study tolterodine tartrate pharmacokinetic, bioavailability and bioequivalence in 12 healthy male volunteers.
Manuscripts that are Published Ahead of Print have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear in their original format and may not be copy edited or formatted in the style guide of this Journal. While accepted manuscripts are not yet assigned a volume, issue or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. The contents of the manuscript may change before it is published in its final form. Manuscripts in this section will be removed once they have been issued to a volume and issue, but will still retain the DOI and date of e-publication.